Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription 11.06.2018 1 Am J Pathol 2 Ann Oncol 3 Ann Surg Oncol 1 BMC Cancer 1 BMJ 3 Br J Cancer 2 Breast Cancer Res 8 Breast Cancer Res Treat 1 Cancer Chemother Pharmacol 2 Clin Breast Cancer 1 Eur J Cancer 4 Eur J Surg Oncol 1 Gene 1 J Clin Oncol 3 J Natl Cancer Inst 4 N Engl J Med 2 PLoS One 2 Radiology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Pathol

1. BORCHERDING N, Cole K, Kluz P, Jorgensen M, et al
   Reevaluating E-cadherin and beta-catenin: A pan-cancer proteomic approach with an emphasis on breast cancer.
   Am J Pathol. 2018 Jun 4. pii: S0002-9440(18)30113.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

2. YARDLEY DA, Coleman R, Conte P, Cortes J, et al
   nab-Paclitaxel Plus Carboplatin or Gemcitabine vs Gemcitabine Plus Carboplatin as First-Line Treatment for Patients With Triple-Negative Metastatic Breast Cancer: Results From the tnAcity Trial.
   Ann Oncol. 2018 Jun 6. pii: 5033593. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
3. POGGIO F, Bruzzone M, Ceppi M, Ponde NF, et al
   Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis.
   Ann Oncol. 2018 Jun 4. pii: 5026316. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

4. WELLINGTON J, Sanders T, Mylander C, Alden A, et al
   Routine Axillary Ultrasound for Patients with T1-T2 Breast Cancer Does Not Increase the Rate of Axillary Lymph Node Dissection Based on Predictive Modeling.
   Ann Surg Oncol. 2018 Jun 4. pii: 10.1245/s10434-018-6545.
   PubMed     Text format     Abstract available
   
   
5. GROSSMITH S, Nguyen A, Hu J, Plichta JK, et al
   Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series.
   Ann Surg Oncol. 2018 Jun 4. pii: 10.1245/s10434-018-6525.
   PubMed     Text format     Abstract available
   
   
6. LANG JE, Ring A, Porras T, Kaur P, et al
   RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.
   Ann Surg Oncol. 2018 Jun 4. pii: 10.1245/s10434-018-6540.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

7. DUSENGIMANA JMV, Hategekimana V, Borg R, Hedt-Gauthier B, et al
   Pregnancy-associated breast cancer in rural Rwanda: the experience of the Butaro Cancer Center of Excellence.
   BMC Cancer. 2018;18:634.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

8. MAYOR S
   Seven in 10 women with early breast cancer do not need chemotherapy, study finds.
   BMJ. 2018;361:k2473.
   PubMed     Text format    
   
   

   
   Br J Cancer

9. ROHAN TE, Miller CA, Li T, Wang Y, et al
   Somatic mutations in benign breast disease tissue and risk of subsequent invasive breast cancer.
   Br J Cancer. 2018 Jun 6. pii: 10.1038/s41416-018-0089.
   PubMed     Text format     Abstract available
   
   
10. TUNG NM, Garber JE
    BRCA1/2 testing: therapeutic implications for breast cancer management.
    Br J Cancer. 2018 Jun 5. pii: 10.1038/s41416-018-0127.
    PubMed     Text format     Abstract available
    
    
11. DERKS MGM, Bastiaannet E, Kiderlen M, Hilling DE, et al
    Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group.
    Br J Cancer. 2018 Jun 7. pii: 10.1038/s41416-018-0090.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res

12. BENSEN JT, Graff M, Young KL, Sethupathy P, et al
    A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.
    Breast Cancer Res. 2018;20:45.
    PubMed     Text format     Abstract available
    
    
13. HRUSKA CB, Geske JR, Swanson TN, Mammel AN, et al
    Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study.
    Breast Cancer Res. 2018;20:46.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res Treat

14. ARIAS-PULIDO H, Cimino-Mathews A, Chaher N, Qualls C, et al
    The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
    Breast Cancer Res Treat. 2018 Jun 1. pii: 10.1007/s10549-018-4834.
    PubMed     Text format     Abstract available
    
    
15. EVANS A, Sim YT, Pourreyron C, Thompson A, et al
    Pre-operative stromal stiffness measured by shear wave elastography is independently associated with breast cancer-specific survival.
    Breast Cancer Res Treat. 2018 Jun 1. pii: 10.1007/s10549-018-4836.
    PubMed     Text format     Abstract available
    
    
16. REDDY JP, Atkinson RL, Larson R, Burks JK, et al
    Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.
    Breast Cancer Res Treat. 2018 Jun 1. pii: 10.1007/s10549-018-4835.
    PubMed     Text format     Abstract available
    
    
17. PICADO O, Khazeni K, Allen C, Yakoub D, et al
    Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy.
    Breast Cancer Res Treat. 2018 Jun 5. pii: 10.1007/s10549-018-4840.
    PubMed     Text format     Abstract available
    
    
18. LOTSCH J, Sipila R, Tasmuth T, Kringel D, et al
    Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy.
    Breast Cancer Res Treat. 2018 Jun 6. pii: 10.1007/s10549-018-4841.
    PubMed     Text format     Abstract available
    
    
19. KONG AL, Nattinger AB, McGinley E, Pezzin LE, et al
    The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer.
    Breast Cancer Res Treat. 2018 Jun 5. pii: 10.1007/s10549-018-4837.
    PubMed     Text format     Abstract available
    
    
20. ROUMELIOTIS M, Long K, Phan T, Graham D, et al
    Including internal mammary lymph nodes in radiation therapy for synchronous bilateral breast cancer: an international survey of treatment technique and clinical priorities.
    Breast Cancer Res Treat. 2018 Jun 5. pii: 10.1007/s10549-018-4848.
    PubMed     Text format     Abstract available
    
    
21. CHA YJ, Ahn SG, Bae SJ, Yoon CI, et al
    Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis.
    Breast Cancer Res Treat. 2018 Jun 5. pii: 10.1007/s10549-018-4842.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Chemother Pharmacol

22. IIZUMI S, Shimomura A, Shimoi T, Sudo K, et al
    Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study.
    Cancer Chemother Pharmacol. 2018 Jun 5. pii: 10.1007/s00280-018-3617.
    PubMed     Text format     Abstract available
    
    

    
    Clin Breast Cancer

23. MCINTIRE PJ, Irshaid L, Liu Y, Chen Z, et al
    Hot Spot and Whole-Tumor Enumeration of CD8(+) Tumor-Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30839.
    PubMed     Text format     Abstract available
    
    
24. CO M, Ng J, Kwong A
    Air Travel Safety in Postoperative Breast Cancer Patients: A Systematic Review.
    Clin Breast Cancer. 2018 May 17. pii: S1526-8209(18)30236.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

25. MILLS MN, Yang GQ, Oliver DE, Liveringhouse CL, et al
    Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis.
    Eur J Cancer. 2018;98:48-58.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

26. LAYEEQUR RAHMAN R, Marshall AJ
    Evidence basis for sentinel node biopsy post neoadjuvant chemotherapy - Bias is a 4-letter word.
    Eur J Surg Oncol. 2018;44:541-542.
    PubMed     Text format    
    
    
27. KUERER HM
    Navigating treatment controversies for DCIS in the era of genomic profiling and active surveillance trials.
    Eur J Surg Oncol. 2018;44:386-387.
    PubMed     Text format    
    
    
28. MAXWELL AJ, Clements K, Hilton B, Dodwell DJ, et al
    Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
    Eur J Surg Oncol. 2018;44:429-435.
    PubMed     Text format     Abstract available
    
    
29. ARISTEI C, Kaidar-Person O, Tagliaferri L, Arenas M, et al
    The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report.
    Eur J Surg Oncol. 2018;44:436-443.
    PubMed     Text format     Abstract available
    
    

    
    Gene

30. REZAIE Z, Ardeshirylajimi A, Ashkezari MD
    Improved anticancer properties of stem cells derived exosomes by prolonged release from PCL nanofibrous structure.
    Gene. 2018 May 2. pii: S0378-1119(18)30480-3. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

31. SLAMON DJ, Neven P, Chia S, Fasching PA, et al
    Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3.
    J Clin Oncol. 2018 Jun 3:JCO2018789909. doi: 10.1200/JCO.2018.78.9909.
    PubMed     Text format     Abstract available
    
    

    
    J Natl Cancer Inst

32. CATHCART-RAKE E, Gast KC, Ruddy KJ
    What Can We Learn From Menstrual Patterns After Treatment for HER2-Positive Breast Cancer?
    J Natl Cancer Inst. 2018 Jun 5. pii: 5033462. doi: 10.1093.
    PubMed     Text format    
    
    
33. LAMBERTINI M, Campbell C, Bines J, Korde LA, et al
    Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.
    J Natl Cancer Inst. 2018 Jun 5. pii: 5033460. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
34. RITZWOLLER DP, Hassett MJ, Uno H, Cronin AM, et al
    Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm.
    J Natl Cancer Inst. 2018;110:273-281.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

35. ELMORE SNC
    p53 and Me.
    N Engl J Med. 2018;378:1962-1963.
    PubMed     Text format    
    
    
36. FRANCIS PA, Pagani O, Fleming GF, Walley BA, et al
    Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
    N Engl J Med. 2018 Jun 4. doi: 10.1056/NEJMoa1803164.
    PubMed     Text format     Abstract available
    
    
37. LIPPMAN ME
    Endocrine Adjuvant Therapy for Localized Breast Cancer.
    N Engl J Med. 2018 Jun 4. doi: 10.1056/NEJMe1806130.
    PubMed     Text format    
    
    
38. SPARANO JA, Gray RJ, Makower DF, Pritchard KI, et al
    Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
    N Engl J Med. 2018 Jun 3. doi: 10.1056/NEJMoa1804710.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

39. FORMA E, Jozwiak P, Ciesielski P, Zaczek A, et al
    Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
    PLoS One. 2018;13:e0198351.
    PubMed     Text format     Abstract available
    
    
40. GU S, Ngamcherdtrakul W, Reda M, Hu Z, et al
    Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.
    PLoS One. 2018;13:e0198141.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

41. PATTACINI P, Nitrosi A, Rossi PG, Iotti V, et al
    Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial.
    Radiology. 2018 Jun 5:172119. doi: 10.1148/radiol.2018172119.
    PubMed     Text format     Abstract available
    
    
42. KANG SK, Jiang M, Duszak R Jr, Heller SL, et al
    Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries.
    Radiology. 2018 Jun 5:172326. doi: 10.1148/radiol.2018172326.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: